brusatol has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, X; Fan, X; Li, M; Sun, B; Wang, B; Xiao, T; Yang, J; Yin, T; Zhang, B | 1 |
1 other study(ies) available for brusatol and Ovarian Neoplasms
| Article | Year |
|---|---|
Inhibitory effects of brusatol delivered using glycosaminoglycan‑placental chondroitin sulfate A‑modified nanoparticles on the proliferation, migration and invasion of cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chondroitin Sulfates; Female; Glycosaminoglycans; Humans; Ovarian Neoplasms; Quassins; Signal Transduction; Wound Healing | 2020 |